SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-002047
Filing Date
2014-05-12
Accepted
2014-05-12 16:30:53
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-10q_20140331.htm 10-Q 1751662
2 EXHIBIT 31.1 rare-ex31_20140331345.htm EX-31 16610
3 EXHIBIT 31.2 rare-ex31_20140331346.htm EX-31 16750
4 EXHIBIT 32.1 rare-ex32_20140331347.htm EX-32 12083
5 GRAPHIC g2014051219494128649.jpg GRAPHIC 190732
  Complete submission text file 0001564590-14-002047.txt   7561091

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rare-20140331.xml EX-101.INS 1141433
7 XBRL TAXONOMY EXTENSION SCHEMA rare-20140331.xsd EX-101.SCH 42754
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rare-20140331_cal.xml EX-101.CAL 32644
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rare-20140331_def.xml EX-101.DEF 244831
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rare-20140331_lab.xml EX-101.LAB 308197
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rare-20140331_pre.xml EX-101.PRE 282833
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 14833770
SIC: 2834 Pharmaceutical Preparations